Press Releases
Our team at Pharmafocuseurope.com believes that press releases are an important marketing tool for highlighting a client's corporate message and ensuring it reaches their target audience. The feature can be used to publish business agreements, annual reports, financial results, corporate performances, important announcements, and any other important information that needs to be communicated to the target audience. Pharma companies can also use it to launch new products and promote existing ones.
Nxera Pharma’s partner Neurocrine Biosciences Initiates Phase 1 Clinical Study Evaluating Effects of NBI-1117567 in Healthy Adults
Friday, May 10, 2024Nxera Pharma notes that its partner Neurocrine Biosciences Inc a leading neurosciencefocused biopharmaceutical company announced that it has initiated
Rakovina Therapeutics Announces Extensions and Expansions of Strategic Collaborations to Support AI Research
Thursday, May 09, 2024Rakovina Therapeutics Inc a biopharmaceutical company committed to advancing new cancer therapies based on novel DNAdamage response technologies is pleased to announce the expansion of two research collaborations to align
Anixa Biosciences Expands Partnership with Cleveland Clinic to Develop Additional Cancer Vaccines
Thursday, May 09, 2024Anixa Biosciences Inc a clinicalstage biotechnology company focused on the treatment and prevention of cancer today announced that it has entered into a joint development agreement with Cleveland Clinic to develop novel vaccines
Clearmind Medicine Secures Exclusive Global Rights to Breakthrough Psychedelic Compounds for PTSD Treatment
Wednesday, May 08, 2024Clearmind Medicine Inc a clinicalstage biotech company focused on discovery and development of novel psychedelicderived therapeutics to solve major undertreated health problems
Oragenics Partners with Avance Clinical for Phase II Concussion Trial in Australia
Wednesday, May 08, 2024Oragenics Inc a pioneer in developing innovative intranasal pharmaceuticals for neurological disorders today announced a partnership with Avance Clinical a leading Contract Research Organization
Kindeva Drug Delivery and Syntegon install first Versynta microBatch in North America
Wednesday, May 08, 2024Syntegon has sold its newly developed Versynta microBatch production cell to its first US customer Kindeva Drug Delivery will use Versynta microBatch to further expand its suite of aseptic fillfinish contract development and manufacturing CDMO capabi...
European Medicines Agency Validates Bristol Myers Squibb’s Application for Opdivo (nivolumab) Plus Yervoy (ipilimumab) for the First-Line Treatment of Adult Patients with Microsatellite
Tuesday, May 07, 2024Bristol Myers Squibb today announced that the European Medicines Agency has validated its Type II variation application for Opdivo plus Yervoy for the firstline
Bluebird Bio Announces Completion of First Cell Collection for LYFGENIA™ Gene Therapy
Tuesday, May 07, 2024Bluebird Bio Inc announced today that it has completed the first commercial cell collection for LYFGENIA a onetime gene therapy for the treatment of sickle cell disease in patients with a history of vasoocclusive events
ADC Therapeutics Announces Initial Data from Investigator-Initiated Phase 2 Clinical Trial of ZYNLONTA® in Patients with Relapsed/Refractory Marginal Zone Lymphoma
Monday, May 06, 2024ADC Therapeutics SA today announced that initial data from an investigatorinitiated Phase clinical trial evaluating ZYNLONTA demonstrated
Oregon Therapeutics & Lantern Pharma Launch Strategic AI Collaboration to Optimize Development of First-In-Class Drug Candidate XCE853 – A Potent Inhibitor of Cancer Metabolism
Monday, May 06, 2024Lantern Pharma Inc a leading artificial intelligence oncology drug discovery and development company today announced a strategic AIdriven collaboration
